Trending Now
  • An LFJ Conversation with Brenna Legaard, Partner, Invenio LLP

Legal Funding Journal is dedicated to informing and engaging the global legal funding community through daily news, insight, analysis and original content.

Latest News

View All

ILFA Urges Law Commission to Build Consumer Class Actions Regime on the CAT Model, Backed by Litigation Funding

The International Legal Finance Association has responded to the Law Commission's Consumer Class Actions Initial Scoping Questionnaire, which closed on Friday, calling for an opt-out consumer regime modelled on the Competition Appeal Tribunal and supported by access to third-party funding.

ILFA argues that many consumer claims cannot be brought today because existing procedures outside the CAT are poorly suited to group actions: representative actions are of limited use where damages need individual assessment, and Group Litigation Orders are opt-in, complex and expensive. It wants the regime to cover the full range of consumer harms and to be open to small businesses.

On funding, ILFA says all opt-out cases in the CAT are supported by third-party funding and calls for PACCAR to be reversed, as the Civil Justice Council recommended in June 2025. It wants funding terms and payment priorities fixed at certification, so agreed waterfalls cannot be reopened at the end of a claim, and opposes making funder returns contingent on take-up rates.

"Too many consumers and small businesses are harmed by the same unlawful conduct yet have no viable route to redress, because each claim is too small to pursue on its own," said Neil Purslow, Chairman of ILFA's Executive Committee. "A consumer class actions regime of the kind the Law Commission is considering, modelled on the Competition Appeal Tribunal's opt-out regime, would give them one."

"Backed by litigation funding, such a regime would put money back into consumers' pockets at a time when the cost of living remains a pressing concern, instead of letting those responsible keep the proceeds," he added. "It would also make corporate wrongdoers answerable to every consumer they harm, thereby promoting more competitive markets that reward businesses for playing by the rules."

Omni Bridgeway Funds Class Action Against NSW Government Over $144 Million in Unlawful Merchant Fees

Omni Bridgeway is funding a class action against the New South Wales Government on behalf of people who paid merchant fees on card and PayPal transactions with state agencies such as Service NSW and Revenue NSW.

According to Omni Bridgeway's claim page, the claim follows the government's own admission in October 2024 that approximately 92 million card transactions since 2016 had attracted about $144 million in merchant fees levied without a lawful basis. The claim alleges the government received legal advice on four separate occasions from the NSW Crown Solicitor that the practice was unlawful.

The claim alleges that the government owed a duty of care to those who paid the fees and breached it by continuing to charge them, and that it made misleading statements about its right to do so in breach of Australian consumer protection laws. Omni Bridgeway notes that, as at the date of filing, the government had not confirmed whether it would refund the surcharges.

The class covers anyone who paid a merchant fee to the NSW Government between 23 September 2020 and 23 September 2026, for example when renewing a driver licence or vehicle registration, or buying a National Parks annual pass. Piper Alderman is on the record for the class.

The action is funded on a no win, no pay basis. If it succeeds, Omni Bridgeway will recover its costs plus a commission, and it has agreed to cover any adverse costs awarded to the government, so class members face no out-of-pocket exposure.

Mariana Client Committee Seeks Court of Appeal Permission to Challenge Ruling Keeping PGMBM in Place

The client committee in the Mariana dam litigation has taken its fight over who represents more than 400,000 claimants to the Court of Appeal, after the High Court refused it permission to appeal a ruling that left PGMBM, formerly Pogust Goodhead, in control of the claim.

As reported by Legal Business, London disputes boutique Humphries Kerstetter, which acts for the committee, announced on 27 October that it had applied to the Court of Appeal for permission.

The application follows Mr Justice Waksman's October ruling that the committee had no authority to terminate the collective conditional fee agreements or litigation management agreements with PGMBM, and therefore could not appoint Bailey Glasser International to run the next phase of the case. "It is plain to me that Pogust Goodhead's construction is preferred," the judge said at the time, adding that the committee "had no power to instruct BGI." He ordered £300,000 in costs on account.

The dispute has direct consequences for the claim's funding. PGMBM is backed by Gramercy, and the committee's criticisms in the High Court included concerns about the funder. PGMBM had estimated that claimants would face around £2 billion in costs exposure if its contracts were terminated.

The underlying claim arises from the 2015 collapse of the Fundão dam in Brazil. BHP was found strictly liable in November 2025, with a quantum trial listed for 2027. Any appeal on representation would run alongside preparations for that trial.

U.S. Tort Costs Reach $580bn, With Third-Party Litigation Funding Named Among the Drivers

The cost of the U.S. tort system has nearly doubled over a decade, rising from $299.7bn in 2014 to $579.7bn in 2023, according to new research that identifies third-party litigation funding among the factors behind the increase.

As reported by Insurance Business Magazine, the figures come from the U.S. Chamber of Commerce Institute for Legal Reform's 2026 report, *International Tort Costs: A Comparative Analysis*, produced with the Insurance Information Institute. Tort costs grew at roughly twice the rate of the wider economy over the period and about four times the rate of inflation.

Commercial lines accounted for $377.73bn of the total against $202.01bn for personal lines. Other liability at $249.31bn and personal auto at $188.13bn together represent 75.45% of all tort costs. Self-insured and uninsured exposures made up $163.25bn, or 28.16% of the total.

Alongside third-party litigation funding, the report points to social inflation, nuclear verdicts and expanding theories of liability. Michel Léonard, chief economist at the Insurance Information Institute, framed the trend as a structural strain on the casualty market rather than a cyclical one. The analysis projects that U.S. and UK tort costs as a share of GDP will converge around 2029 to 2030.

The report is the latest from a body that has consistently urged disclosure requirements for litigation funding arrangements, and its figures are likely to feature in the state and federal debates now underway.

Harbour Credit Backs £2m Funding Package for Credit Hire Firm’s Management Buyout

Harbour Credit has provided a £2m funding package to Manchester credit hire specialist Garvins Law, financing a management buyout that leaves founder Neil Garvin as the firm's sole shareholder.

As reported by Legal Futures, the package from the lending arm of litigation funder Harbour includes a £1m working capital facility. Garvins Law was founded in 2007 and employs 22 staff, having built its practice around credit hire work following the whiplash reforms. The firm was previously owned by alternative business structure EDAM Group, which entered administration in January 2025; Garvins remained solvent and continued trading throughout.

The firm's accounts for the year to 31 March 2026 show turnover of £2.5m, more than double the prior year, and a profit of £125,000 against a £200,000 loss the year before.

"We have an experienced team, an established position in the credit hire market and ambitious plans to grow the business," said Neil Garvin. Ellora MacPherson is managing director of Harbour Credit.

The transaction illustrates the continuing expansion of litigation funders into law firm lending, where capital is deployed against a practice's receivables and work in progress rather than the outcome of a single case. For claimant firms emerging from the ownership of a collapsed consolidator, that form of credit offers a route to independence without ceding equity to an external investor.

High Court Voids £11m Claim Brought on a Cause of Action Assigned to Solicitors’ Company

The High Court has voided an £11m claim after finding that the cause of action had been assigned to a company in which the solicitors acting on the matter held shares, applying a rule against solicitors purchasing their clients' claims that dates back to 1784.

As reported by Legal Futures, the claim arose from an April 2019 deed of loan from Maltby Services to John Rhoden. The cause of action was assigned first to TD Capital in November 2024 and then to MSV Estates in December 2025. Andrew Hickman and Anthony Page, solicitors at Hickman Construction Law in Worcestershire, each held approximately 11% of the relevant company. Master Sullivan, sitting in the King's Bench Division, applied the so-called "solicitor rule" derived from Hall v Hallet (1784) and held the claim void.

Rejecting the argument that minority shareholdings held through a corporate vehicle took the arrangement outside the rule, the Master said: "The solicitor rule would be hollow if it could be so easily circumvented merely by the solicitors acting through a company. That is no less a forceful argument even if they are minority shareholders."

The ruling is relevant to anyone structuring claim acquisitions rather than conventional funding agreements. It signals that the courts will look through corporate vehicles to the identity of the beneficial owners, and that an assignment which places a client's claim in the hands of the solicitors conducting it risks being set aside entirely rather than merely reduced.

Litigation Capital Management Secures Short Covenant Waiver Extension to 13 November

Litigation Capital Management has obtained a further extension of the covenant waiver on its senior debt facility, buying the funder two additional weeks as it works to complete a longer-term amendment to the facility.

As reported in a regulatory announcement released on 2 November 2026, the waiver agreed with lender Northleaf Capital Partners (Canada) Ltd had been due to expire on 31 October 2026 and has now been extended to 13 November 2026. The company said the short duration reflects the fact that the conditions precedent to the longer-term facility amendment announced on 30 September 2026 are close to being satisfied. The interest rate on the facility remains 2.00% per annum above the standard rate, and no additional waiver fee is payable.

The extension is the latest in a sequence of short waivers running back to December 2025, during which the facility limit was increased from US$75m to US$100m. LCM's strategic review, announced in September 2025, concluded without a transaction, and the company is now in orderly run-off.

For the financial year ended June 2026, LCM reported a loss after tax of A$165.7m and net liabilities of A$53.6m. In October the company disclosed an unsuccessful judgment in an Australian insolvency claim and received a termination notice alleging breach of a funding agreement in a Competition Appeal Tribunal collective action, which LCM disputes. Shares closed at 0.499p on 2 November.

Deceased Class Representative’s Estate Ordered to Pay £7.7m in Costs

The estate of a deceased class representative has been ordered to pay £7.7m in costs after the collective proceedings he brought against a group of UK rail operators collapsed, in a ruling that underscores the adverse costs exposure attaching to opt-out claims in the Competition Appeal Tribunal.

As reported by The Law Society Gazette, the case concerned David Courtney Boyle, who in 2021 brought a claim valued at roughly £400m against Govia Thameslink Railway and other defendants over allegedly inflated fares on London to Brighton routes. Mr Boyle died of Parkinson's disease in June 2025. With no replacement class representative coming forward, the Tribunal revoked the collective proceedings order and the claim was decertified. The Tribunal's Order of the Chair on costs is dated 26 October 2026, and a further costs hearing has been listed for 24 November 2026.

The outcome is the second costs ruling of its kind against a UK class representative in recent months. In May 2026, Walter Merricks CBE was ordered to pay £70,000 in interim costs — against a defence application for £223,000 — after withdrawing from proceedings for want of after-the-event insurance.

For funders, the decision reinforces the centrality of adverse costs cover in the economics of UK collective actions. Where a class representative dies or withdraws and no successor steps in, the claim does not simply lapse: the defendants' costs crystallise, and the question of who ultimately bears them turns on the funding and insurance arrangements put in place at the outset.

An LFJ Conversation with Brenna Legaard, Partner, Invenio LLP

Below is our LFJ Conversation with Brenna Legaard, Partner at Invenio LLP.

Brenna Legaard is an accomplished first chair trial attorney, patent attorney, and intellectual property strategist with more than 20 years of experience advising technology companies on the protection, commercialization, and enforcement of their innovations. Her practice spans high-stakes litigation, strategic IP portfolio development, licensing, and deal support. Brenna has represented Fortune 500 companies and cutting-edge startups alike, guiding clients through patent portfolio development, enforcement campaigns, trademark enforcement, and sophisticated cross-border matters. She is deeply engaged in the evolving landscape of litigation finance, leveraging this important tool to fulfill the promise of the patent system for inventors.

To set the stage, tell us about Invenio and your move there from K&L Gates. Invenio is built around legal underwriting, IP monetization and specialty finance rather than a traditional full-service practice. What did you see in the market that made that the right platform for IP enforcement work in 2026?

After many years in Big Law, I was drawn to how entrepreneurial and nimble Invenio is. The legal market, and what clients need from it, is changing fast. I wanted to be somewhere built to respond to that change in ways that are both innovative and disciplined.

Litigation finance was a big part of the draw, too. I spent 25 years helping companies get patents, build portfolios and protect their IP. When litigation finance arrived, it was a remarkable tool. In the right circumstances, it lets a patent owner actually use that IP without cost standing in the way. Invenio's focus on that space gave me the chance to bring the two halves of my career together. It also lets me do more plaintiff-side work than I'd been able to before.

IP underwriting is where a great deal of capital is won or lost. Walk us through what rigorous underwriting of a patent matter actually looks like in practice. What separates a genuinely fundable case from one that merely looks good on paper, and where does diligence most often fall short?

Every patent case comes down to three questions. Are the patents infringed? Are they valid? And are the damages large enough to justify the investment? Those questions are usually treated as separate workstreams, but they're deeply intertwined. When you interpret the claims for infringement, you're committing to a particular claim scope, and you have to live with that same scope on validity and damages. So the real question is whether the claim scope you need for infringement is also valid, and valuable enough to support robust damages. The most common failure I see in underwriting is answering those questions in silos instead of as one interdependent analysis.

The second place diligence falls short is in understanding the real technical value of the invention. Too often, people treat sales figures as a proxy instead of asking whether the industry truly needs the innovation.

Finally, I have strong views on how AI should, and shouldn't, be used in IP underwriting, which I've written about here.

Patent investments are multi-year commitments, but the policy environment around them moves faster than that. USPTO leadership, PTAB practice and discretionary denial standards can all shift with a change in administration. How should funders future-proof IP investments against that volatility, and what does a durable enforcement strategy look like when the rules may change mid-case?

I don't believe your direction should change with the administration. What changes is whether the policy landscape gives you headwinds or tailwinds, but if your direction is sound, you keep heading there either way.

The North Star in patent litigation is claims that are valid and technologically important. That's what preserves a case's value in a hostile environment, and it's what maximizes that value in a friendly one. Right now, the policy climate may let some people get away with looser underwriting. If policy swings back to where it was a few years ago, they won't. The right answer is the right answer, whichever way the wind is blowing.

Large firms that historically defended patent cases are moving onto the plaintiff side, often with contingency or hybrid arrangements. What is driving that shift, and how should funders think about managing those relationships on economics, control, conflicts and case selection compared with working with established plaintiff-side boutiques?

Money, of course. As funding becomes more common and more accepted, and as firms worry less about optics and more about profits per partner, they'll follow the opportunity. But Big Law isn't built to take on risk. Large firms have trouble assessing risk, trouble getting comfortable with it, and trouble doing what needs to be done when it shows up in ways they didn't expect. And their financial model assumes they get paid regardless, which creates friction. Contingency plaintiff firms, by contrast, are built for this work and know how to adapt when the unexpected happens.

My biggest caution to funders is that you can't treat these two kinds of firms the same way. What works with a contingency boutique won't work with a Big Law firm. Those firms are not only risk-averse but systemically risk-intolerant, and their compensation systems aren't designed to reward taking on risk.

To that end, here's my best guidance for funders to navigate the space successfully.

Underwrite the firm, not just the case. Understand how partner compensation treats contingency work, who inside the firm has to sign off, and what happens to the team members' numbers if the case runs long.

Structure the economics around that reality. A hybrid arrangement with a meaningful but survivable fee reduction often keeps a large firm more committed than a pure contingency that its compensation committee will start second-guessing two years in.

Agree on the hard things up front. Settle budgets, staffing and a framework for settlement decisions at the outset, within the ethical limits on funder control. And look for plaintiff experience in the team, as there are big strategic differences between defense and plaintiffs.

Press hard on conflicts, including business conflicts that won't show up in a conflicts check. A firm with a deep defense-side book may face pressure from an important client to step away — pressure that can show up when unexpected risk does.

Be disciplined on case selection. Don't let a firm's appetite for headline-size matters set the agenda.

Looking 18 to 24 months out, you work at the intersection of IP, litigation funding and insurance. Where do you expect capital to find the best risk-adjusted returns in IP, what role will insurance play in de-risking those positions, and where should sophisticated funders be positioning now?

With Big Law moving into the space, there's inflation in what counts as a "good case." A lot of attention goes to the mega-deals, meaning litigations with more than $100 million in damages at stake. But verdicts at that scale often don't survive appeal, if they're reached at all. There's a lot of risk at that size, and funders would be well served by finding ways into cases that don't need as much capital. Learning to make good money at a smaller, more reliable scale matters for the health of the whole industry.

As for insurance: candidly, I don't think any funder should take on a large contingency case without insuring it. Insurance addresses many of the problems created by the way our industry takes on risk, especially when Big Law is involved. It tends to push investments toward aggregated structures. Particularly with Big Law, though, insurance may be what makes those deals viable and sustainable. There isn't always room for it in a smaller deal. But for the big cases and the Big Law work, both firms and funders need to look to insurance to manage the risks built into our business model.

Omni Bridgeway Reaffirms Double-Digit AUM Growth Target Through FY28

Omni Bridgeway has restated its medium-term targets for assets under management and cost coverage, telling investors it expects annualised AUM growth of at least 10% through FY28.

As reported by GlobeNewswire, the Australian funder is also targeting 70% coverage of its operating costs by FY28. Assets under management stand at A$5.9bn, up 12% since June 2025, representing a 17% compound annual growth rate since June 2022.

The cost coverage trajectory is the more telling figure. The measure has moved from 17% in FY23 to 53% in FY26, as the business shifts weight from its own balance sheet toward third-party capital and fee income. Operating expenses fell 20% in FY26 while new commitments rose 38%.

Chief executive Raymond van Hulst has positioned the group around capital-light growth. FY26 produced record proceeds of A$350.5m, up 49%, alongside A$712.2m in new commitments, A$862m of third-party capital and more than A$1.6bn in total capital formation.

The guidance is a reaffirmation rather than a new disclosure, and the targets were set out in the company's FY26 results cycle. Its value lies in the consistency of the message: Omni Bridgeway continues to tell the market that growth will come through managed funds and co-investment rather than through expanding its own book.

Fundraising

View All

Case Developments

View All

Legal Innovation

View All

People Moves

View All

Regulatory

View All

Consumer

View All

Thought Leadership

View All